Skip to content

Clinical trials

Completed Schizophrenia trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Status: Completed Country / region: France Clear all

123 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20032
20043
20054
20065
20078
20088
20094
20105
201111
201210
20139
201414
20152
20169
20174
20185
20196
20204
20214
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed123

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hôpital le Vinatier15
Janssen-Cilag International NV8
Otsuka Pharmaceutical Development & Commercialization, Inc.8
Centre Hospitalier Universitaire de Saint Etienne6
Sumitomo Pharma America, Inc.6
University Hospital, Strasbourg, France6
Assistance Publique - Hôpitaux de Paris5
Hoffmann-La Roche5
Centre Hospitalier Universitaire de Nice4
Eli Lilly and Company4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia123
Psychotic Disorders8
Bipolar Disorder7
Hallucinations6
Dissociative Disorders3
Mental Disorders3
Anxiety Disorders2
Autistic Disorder2
Lethargy2
Major Depressive Disorder2

Trials

Showing 1 to 25 of 123. Each trial links to its page on Pharma Observatory.

23 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.